Stock Ratings | With the stock potentially rising as much as 1292.41%, Guggenheim maintained its "Buy" recommendation on InflaRx (IFRX) and raised its price target from $10 to $22.
Sahm Platform 11/11 09:18
Raymond James Maintains Outperform on Seacoast Banking, Lowers Price Target to $23
Seacoast Banking Corporation of Florida SBCF | 0.00 |
